Posters Archives - 91桃色视频 /fr/category/posters-fr/ microbiota gut to fight cancer Mon, 23 Mar 2026 10:30:36 +0000 fr-FR hourly 1 https://wordpress.org/?v=6.8.3 /wp-content/uploads/2018/10/cropped-logo-maat-pharma-author-32x32.png Posters Archives - 91桃色视频 /fr/category/posters-fr/ 32 32 Key Results from the CHRONOS Multicentre Retrospective Cohort Study Describing Patient Outcomes in Third-Line Acute Gastrointestinal GvHD /fr/key-results-from-the-chronos-multicentre-retrospective-cohort-study-describing-patient-outcomes-in-third-line-acute-gastrointestinal-gvhd/ Thu, 26 Feb 2026 16:01:05 +0000 /?p=24523 T茅l茅charger le poster 📎

The post Key Results from the CHRONOS Multicentre Retrospective Cohort Study Describing Patient Outcomes in Third-Line Acute Gastrointestinal GvHD appeared first on 91桃色视频.

]]>

The post Key Results from the CHRONOS Multicentre Retrospective Cohort Study Describing Patient Outcomes in Third-Line Acute Gastrointestinal GvHD appeared first on 91桃色视频.

]]>
THRASSA, A Multicenter, Open-label Study Evaluating The Safety, Tolerability And Efficacy Of MaaT013 In Ruxolitinib-refractory Or Intolerant Paediatric/ Adolescent Participants With Gastrointestinal Acute Graft-versus-Host Disease /fr/thrassa-a-multicenter-open-label-study-evaluating-the-safety-tolerability-and-efficacy-of-maat013-in-ruxolitinib-refractory-or-intolerant-paediatric-adolescent-participants-with-gastrointestinal-a/ Thu, 26 Feb 2026 15:49:26 +0000 /?p=24505 T茅l茅charger le poster 📎

The post THRASSA, A Multicenter, Open-label Study Evaluating The Safety, Tolerability And Efficacy Of MaaT013 In Ruxolitinib-refractory Or Intolerant Paediatric/ Adolescent Participants With Gastrointestinal Acute Graft-versus-Host Disease appeared first on 91桃色视频.

]]>

The post THRASSA, A Multicenter, Open-label Study Evaluating The Safety, Tolerability And Efficacy Of MaaT013 In Ruxolitinib-refractory Or Intolerant Paediatric/ Adolescent Participants With Gastrointestinal Acute Graft-versus-Host Disease appeared first on 91桃色视频.

]]>
MaaT033 For Gut Microbiota Optimization To Improve Survival After Allogenic HCT: The PHOEBUS Trial /fr/maat033-for-gut-microbiota-optimization-to-improve-survival-after-allogenic-hct-the-phoebus-trial/ Thu, 26 Feb 2026 10:46:12 +0000 /?p=24439 T茅l茅charger le poster 📎

The post MaaT033 For Gut Microbiota Optimization To Improve Survival After Allogenic HCT: The PHOEBUS Trial appeared first on 91桃色视频.

]]>

The post MaaT033 For Gut Microbiota Optimization To Improve Survival After Allogenic HCT: The PHOEBUS Trial appeared first on 91桃色视频.

]]>
MaaT013 Pooled Fecal Microbiotherapy Improves Gastrointestinal Physiology And Controls Inflammation Which Delays GvHD In A Proof-Of-Concept Humanized Mouse Study /fr/maat013-pooled-fecal-microbiotherapy-improves-gastrointestinal-physiology-and-controls-inflammation-which-delays-gvhd-in-a-proof-of-concept-humanized-mouse-study-2/ Wed, 12 Nov 2025 12:56:24 +0000 /?p=16968   Download the poster

The post MaaT013 Pooled Fecal Microbiotherapy Improves Gastrointestinal Physiology And Controls Inflammation Which Delays GvHD In A Proof-Of-Concept Humanized Mouse Study appeared first on 91桃色视频.

]]>

 

The post MaaT013 Pooled Fecal Microbiotherapy Improves Gastrointestinal Physiology And Controls Inflammation Which Delays GvHD In A Proof-Of-Concept Humanized Mouse Study appeared first on 91桃色视频.

]]>
MaaT034, a new co-cultured microbiome ecosystem therapy candidate, potentiates anti-PD1 mediated antitumoral activity in germ-free mice /fr/maat034-a-new-co-cultured-microbiome-ecosystem-therapy-candidate-potentiates-anti-pd1-mediated-antitumoral-activity-in-germ-free-mice-2/ Wed, 05 Nov 2025 09:27:48 +0000 /?p=16948   T茅l茅charger le poster

The post MaaT034, a new co-cultured microbiome ecosystem therapy candidate, potentiates anti-PD1 mediated antitumoral activity in germ-free mice appeared first on 91桃色视频.

]]>

 

The post MaaT034, a new co-cultured microbiome ecosystem therapy candidate, potentiates anti-PD1 mediated antitumoral activity in germ-free mice appeared first on 91桃色视频.

]]>
MaaT034, a new co-cultured microbiome ecosystem therapy candidate, safely colonizes the gastro-intestinal tract of germ-free mice to restore a healthy gut physiology and stimulates immunity /fr/maat034-a-new-co-cultured-microbiome-ecosystem-therapy-candidate-safely-colonizes-the-gastro-intestinal-tract-of-germ-free-mice-to-restore-a-healthy-gut-physiology-and-stimulates-immunity/ Mon, 28 Apr 2025 16:22:23 +0000 /?p=14975 T茅l茅charger le poster

The post MaaT034, a new co-cultured microbiome ecosystem therapy candidate, safely colonizes the gastro-intestinal tract of germ-free mice to restore a healthy gut physiology and stimulates immunity appeared first on 91桃色视频.

]]>

The post MaaT034, a new co-cultured microbiome ecosystem therapy candidate, safely colonizes the gastro-intestinal tract of germ-free mice to restore a healthy gut physiology and stimulates immunity appeared first on 91桃色视频.

]]>
MaaT033 pour assurer un microbiote intestinal optimal afin d’am茅liorer la survie des patients recevant une allo-CSH : Essai PHOEBUS /fr/maat033-pour-assurer-un-microbiote-intestinal-optimal-afin-dameliorer-la-survie-des-patients-recevant-une-allo-csh-essai-phoebus/ Mon, 02 Dec 2024 15:33:17 +0000 /?p=13647 T茅l茅charger le poster

The post MaaT033 pour assurer un microbiote intestinal optimal afin d’am茅liorer la survie des patients recevant une allo-CSH : Essai PHOEBUS appeared first on 91桃色视频.

]]>

The post MaaT033 pour assurer un microbiote intestinal optimal afin d’am茅liorer la survie des patients recevant une allo-CSH : Essai PHOEBUS appeared first on 91桃色视频.

]]>
PHOEBUS Trial: an international, randomized, double-blind, multicenter phase IIb study evaluating MaaT033, oral allogeneic fecal microbiotherapy, in patients undergoing allo-HSCT to improve overall survival. SEHH Congress (Spanish only) /fr/sehh-phoebus-trial-an-international-randomized-double-blind-multicenter-phase-iib-study-evaluating-maat033-oral-allogeneic-fecal-microbiotherapy-in-patients-undergoing-allo-hsct-to-improve-ove/ Mon, 02 Dec 2024 15:30:59 +0000 /?p=13633 T茅l茅charger le poster

The post PHOEBUS Trial: an international, randomized, double-blind, multicenter phase IIb study evaluating MaaT033, oral allogeneic fecal microbiotherapy, in patients undergoing allo-HSCT to improve overall survival. SEHH Congress (Spanish only) appeared first on 91桃色视频.

]]>

The post PHOEBUS Trial: an international, randomized, double-blind, multicenter phase IIb study evaluating MaaT033, oral allogeneic fecal microbiotherapy, in patients undergoing allo-HSCT to improve overall survival. SEHH Congress (Spanish only) appeared first on 91桃色视频.

]]>
Evaluation of a new co-cultured Microbiome Ecosystem Therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors /fr/evaluation-of-a-new-co-cultured-microbiome-ecosystem-therapy-candidate-maat03x-for-clinical-testing-as-adjuvant-neoadjuvant-to-immune-checkpoint-inhibitors-in-solid-tumors-2/ Fri, 29 Nov 2024 14:02:12 +0000 /?p=13380 T茅l茅charger le poster

The post Evaluation of a new co-cultured Microbiome Ecosystem Therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors appeared first on 91桃色视频.

]]>

The post Evaluation of a new co-cultured Microbiome Ecosystem Therapy candidate (MaaT03X) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors appeared first on 91桃色视频.

]]>
Baseline and Safety data from IASO, a pioneering open-label phase 1b trial assessing the safety, tolerability and gut microbiota analysis of an oral microbiotherapy in amyotrophic lateral sclerosis Dispose d鈥檜n menu contextuel Dispose d鈥檜n menu contextuel /fr/baseline-and-safety-data-from-iaso-a-pioneering-open-label-phase-1b-trial-assessing-the-safety-tolerability-and-gut-microbiota-analysis-of-an-oral-microbiotherapy-in-amyotrophic-lateral-sclerosis-di/ Mon, 18 Nov 2024 11:23:31 +0000 /?p=11228 Coming soon!

The post Baseline and Safety data from IASO, a pioneering open-label phase 1b trial assessing the safety, tolerability and gut microbiota analysis of an oral microbiotherapy in amyotrophic lateral sclerosis Dispose d鈥檜n menu contextuel Dispose d鈥檜n menu contextuel appeared first on 91桃色视频.

]]>
Coming soon!

The post Baseline and Safety data from IASO, a pioneering open-label phase 1b trial assessing the safety, tolerability and gut microbiota analysis of an oral microbiotherapy in amyotrophic lateral sclerosis Dispose d鈥檜n menu contextuel Dispose d鈥檜n menu contextuel appeared first on 91桃色视频.

]]>